Biocompatible nanopolymers: the next generation of breast cancer treatment?

Author： Ljubimova Julia Y   Holler Eggehard  

Publisher： Future Medicine

ISSN： 1743-5889

Source： Nanomedicine, Vol.7, Iss.10, 2012-10, pp. : 1467-1470

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The next generation of epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of lung cancer

By  

CANCER, Vol. 121, Iss. 8, 2015-04 ,pp. : E1-E6

John Wiley & Sons Inc

Access to resources Recommend Favorite

Genetic predisposition to breast cancer: The next chapters

By  

CANCER, Vol. 120, Iss. 7, 2014-04 ,pp. : 932-934

John Wiley & Sons Inc

Access to resources Recommend Favorite

RESULTS IN TREATMENT OF CANCER OF THE BREAST

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 1, Iss. 9, 1953-09 ,pp. : 642-647

John Wiley & Sons Inc

Access to resources Recommend Favorite

Gemcitabine-loaded biocompatible nanocapsules for the effective treatment of human cancer

By Paolino Donatella   Cosco Donato   Celano Marilena   Moretti Sonia   Puxeddu Efisio   Russo Diego   Fresta Massimo  

Nanomedicine, Vol. 8, Iss. 2, 2013-02 ,pp. : 193-201

Future Medicine

Access to resources Recommend Favorite

Rivizor – A New Third-Generation Aromatase Inhibitor for the Treatment of Advanced Breast Cancer after Tamoxifen Failure

By  

Oncology, Vol. 56, Iss. 2, 1999-02 ,pp. : 114-121

Karger

Access to resources Recommend Favorite